Asian journal of psychiatry · 2026
Translation and reliability of the metacognition self-assessment scale and the metacognition questionnaire in the Indian context.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Grover Sandeep, Redhu Promil, Nehra Ritu, Mehra Aseem, Carcione Antonino
Аннотация
BACKGROUND: The available metacognition scales have not been translated in the Indian population.
AIM: This study aimed to translate the Metacognition Self-Assessment Scale (MSAS) and the Metacognition Questionnaire (MCQ-30) into Hindi and to evaluate the internal consistency and split-half reliability of the Hindi versions. Additional objectives were to compare the metacognitive impairments among schizophrenia patients and healthy controls.
METHODOLOGY: MSAS and MCQ-30 were translated into Hindi using the World Health Organisation guidelines, and the Hindi versions were administered to 100 schizophrenia patients and 117 healthy controls enrolled through convenience sampling.
RESULTS: The Cronbach's alpha of MSAS was 0.949 and 0.899 for the schizophrenia and control groups, respectively. The Cronbach's alpha of MCQ-30 was 0.9 and 0.826, for the schizophrenia and control groups, respectively. Patients with schizophrenia performed poorly on MSAS when compared to healthy controls. However, on MCQ-30, both groups were comparable.
CONCLUSIONS: The present study also suggests that patients with schizophrenia perform poorly on MSAS when compared to healthy controls. However, on MCQ-30, both groups are comparable in metacognition functioning.
AIM: This study aimed to translate the Metacognition Self-Assessment Scale (MSAS) and the Metacognition Questionnaire (MCQ-30) into Hindi and to evaluate the internal consistency and split-half reliability of the Hindi versions. Additional objectives were to compare the metacognitive impairments among schizophrenia patients and healthy controls.
METHODOLOGY: MSAS and MCQ-30 were translated into Hindi using the World Health Organisation guidelines, and the Hindi versions were administered to 100 schizophrenia patients and 117 healthy controls enrolled through convenience sampling.
RESULTS: The Cronbach's alpha of MSAS was 0.949 and 0.899 for the schizophrenia and control groups, respectively. The Cronbach's alpha of MCQ-30 was 0.9 and 0.826, for the schizophrenia and control groups, respectively. Patients with schizophrenia performed poorly on MSAS when compared to healthy controls. However, on MCQ-30, both groups were comparable.
CONCLUSIONS: The present study also suggests that patients with schizophrenia perform poorly on MSAS when compared to healthy controls. However, on MCQ-30, both groups are comparable in metacognition functioning.